Exact Mass: 589.1169663999999
Exact Mass Matches: 589.1169663999999
Found 75 metabolites which its exact mass value is equals to given mass value 589.1169663999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ADP-glucose
C16H25N5O15P2 (589.0822360000001)
ADP-glucose serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. ADP-glucose has been found to be a metabolite of Escherichia (PMID: 25102309). Acquisition and generation of the data is financially supported in part by CREST/JST.
GDP-L-fucose
C16H25N5O15P2 (589.0822360000001)
GDP-L-fucose is a sugar nucleotide and a readily available source of fucose. Fucose is a deoxyhexose that is found in nearly all plant and animal species. The monosaccharide plays several important metabolic roles in complex carbohydrates and in glycoproteins. Fucosylated oligosaccharides are involved in cell-cell recognition, selectin-mediated leukocyte-endothelial adhesion, and mouse embryogenesis. They form the basis of the Lewis-type blood group antigens, are involved in the formation of atherosclerosis, and mediate host-bacterial interactions. A decrease in the availability of fucose is associated with leukocyte adhesion deficiency type-II disorder, and fucosylated glycoproteins have been implicated in memory processes. Fucose is made available during the synthesis of fucosylated glycolipids, oligosaccharides, and glycoproteins via a sugar nucleotide intermediate, specifically GDP-L-fucose. GTP-L-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-L-fucose-1-phosphate to form the nucleotide-sugar GDP-L-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free L-fucose during the breakdown of glycolipids and glycoproteins. (PMID: 16086588). Gdp-l-fucose, also known as gdp fucose or guanosine diphosphate fucose, is a member of the class of compounds known as purine nucleotide sugars. Purine nucleotide sugars are purine nucleotides bound to a saccharide derivative through the terminal phosphate group. Gdp-l-fucose is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gdp-l-fucose can be found in a number of food items such as breadnut tree seed, okra, pineapple, and pitanga, which makes gdp-l-fucose a potential biomarker for the consumption of these food products. Gdp-l-fucose can be found primarily throughout most human tissues. Gdp-l-fucose exists in all living organisms, ranging from bacteria to humans. In humans, gdp-l-fucose is involved in a couple of metabolic pathways, which include fructose and mannose degradation and fructose intolerance, hereditary. Gdp-l-fucose is also involved in fructosuria, which is a metabolic disorder. Acquisition and generation of the data is financially supported in part by CREST/JST.
UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose
dTDP-4-acetamido-4,6-dideoxy-D-galactose
C18H29N3O15P2 (589.1073864000001)
dTDP-4-acetamido-4,6-dideoxy-D-galactose reacts with undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate to produce undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate-4-acetamido-4,6-dideoxy-D-galactose pyrophosphate and dTDP. The reaction is catalyzed by certain members of the fucosyltransferase family of enzymes. [HMDB] dTDP-4-acetamido-4,6-dideoxy-D-galactose reacts with undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate to produce undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate-4-acetamido-4,6-dideoxy-D-galactose pyrophosphate and dTDP. The reaction is catalyzed by certain members of the fucosyltransferase family of enzymes.
dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose
C19H33N3O14P2 (589.1437698000001)
dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose
C18H29N3O15P2 (589.1073864000001)
GDP-D-Rhamnose
C16H25N5O15P2 (589.0822360000001)
GDP-D-rhamnose is produced in virus-infected cells. Rhamnose is components of the glycans attached to capsid protein, the pathway could circumvent a limited supply of GDP sugars by the algal host.(http://www.jbc.org/cgi/content/abstract/278/24/21559) [HMDB] GDP-D-rhamnose is produced in virus-infected cells. Rhamnose is components of the glycans attached to capsid protein, the pathway could circumvent a limited supply of GDP sugars by the algal host.(http://www.jbc.org/cgi/content/abstract/278/24/21559).
ADP-Mannose
C16H25N5O15P2 (589.0822360000001)
ADP-mannose is one of the major substrates of human hydrolases. Nudix hydrolases catalyze the hydrolysis of a variety of nucleoside diphosphate derivatives, and ADP-sugar pyrophosphatase are non-specific nucleoside diphosphosugar or diphosphoalcohol (NDP-X) pyrophosphatases, which hydrolyse some nonreducing NDP-X substrates. It has been found in erythrocytes, placenta and liver. (PMID: 1128712, 10722730, 9693963) [HMDB] ADP-mannose is one of the major substrates of human hydrolases. Nudix hydrolases catalyze the hydrolysis of a variety of nucleoside diphosphate derivatives, and ADP-sugar pyrophosphatase are non-specific nucleoside diphosphosugar or diphosphoalcohol (NDP-X) pyrophosphatases, which hydrolyse some nonreducing NDP-X substrates. It has been found in erythrocytes, placenta and liver. (PMID: 1128712, 10722730, 9693963).
UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose
[(2~{R},3~{R},4~{S},5~{S},6~{R})-4-acetamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2~{R},3~{S},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate
C18H29N3O15P2 (589.1073864000001)
dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose
C18H29N3O15P2 (589.1073864000001)
UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-hex-4-ulose
GDP-fucose
C16H25N5O15P2 (589.0822360000001)
GDP-L-fucose is a sugar nucleotide and a readily available source of fucose. Fucose is a deoxyhexose that is found in nearly all plant and animal species. The monosaccharide plays several important metabolic roles in complex carbohydrates and in glycoproteins. Fucosylated oligosaccharides are involved in cell-cell recognition, selectin-mediated leukocyte-endothelial adhesion, and mouse embryogenesis. They form the basis of the Lewis-type blood group antigens, are involved in the formation of atherosclerosis, and mediate host-bacterial interactions. A decrease in the availability of fucose is associated with leukocyte adhesion deficiency type-II disorder, and fucosylated glycoproteins have been implicated in memory processes. Fucose is made available during the synthesis of fucosylated glycolipids, oligosaccharides, and glycoproteins via a sugar nucleotide intermediate, specifically GDP-L-fucose. GTP-L-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-L-fucose-1-phosphate to form the nucleotide-sugar GDP-L-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free L-fucose during the breakdown of glycolipids and glycoproteins. (PMID: 16086588) [HMDB]
Adenosine-5-diphospho-glucose disodium salt
C16H25N5O15P2 (589.0822360000001)
Guanosine-5-diphospho-beta-L-fucose
C16H25N5O15P2 (589.0822360000001)
TDP-4-acetamido-4,6-Dideoxy-D-galactose
C18H29N3O15P2 (589.1073864000001)
Pinaverium bromide
C26H41Br2NO4 (589.1402145999999)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Exicorilant
C26H23F4N7O3S (589.1519136000001)
C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C183052 - Glucocorticoid Receptor Antagonist C147908 - Hormone Therapy Agent
[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
C16H25N5O15P2 (589.0822360000001)
UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine
C17H27N4O15P2- (589.0948112000001)
UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-idosamine
C17H27N4O15P2- (589.0948112000001)
UDP-acetamido-4-amino-6-deoxygalactopyranose
C17H27N4O15P2- (589.0948112000001)
dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-beta-L-arabino-hexopyranose
C18H29N3O15P2 (589.1073864000001)
UDP-N-acetylgalactosamine-5,6-ene
A UDP-amino sugar having N-acetylgalactosamine-5,6-ene as the amino sugar component.
[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,4S,5R,6R)-5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl] hydrogen phosphate
C18H29N3O15P2 (589.1073864000001)
[(2R,3R,4R,5S)-3-acetamido-4,5-dihydroxy-6-methylideneoxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
thymidine 5-[3-(4-acetamido-4,6-dideoxy-D-galactopyranosyl) dihydrogen diphosphate]
C18H29N3O15P2 (589.1073864000001)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C29H27ClF3N3O5 (589.1591238000001)
dTDP-4-acetamido-4,6-dideoxy-D-glucose
C18H29N3O15P2 (589.1073864000001)
UDP-2-acetamido-4-dehydro-2,6-dideoxy-beta-D-glucose
UDP-2-acetamido-4-amino-2,4,6-trideoxy-D-glucose(1-)
C17H27N4O15P2- (589.0948112000001)
[[(2S,3R,4S,5S)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl] hydrogen phosphate
C16H25N5O15P2 (589.0822360000001)
GDP-L-fucose
C16H25N5O15P2 (589.0822360000001)
A GDP-fucose in which the fucosyl residue has L-configuration.
UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose
dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose
C18H29N3O15P2 (589.1073864000001)
dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-L-mannose
C19H33N3O14P2 (589.1437698000001)
ADP alpha-D-glucoside
C16H25N5O15P2 (589.0822360000001)
An ADP-aldose having alpha-D-glucopyranose as the sugar moiety.
GDP-beta-L-Fucose
C16H25N5O15P2 (589.0822360000001)
A GDP-L-fucose in which the anomeric oxygen is on the same side of the fucose ring as the methyl substituent.
dTDP-4-acetamido-4,6-dideoxy-glucose
C18H29N3O15P2 (589.1073864000001)
6H05 (TFA)
C22H31ClF3N3O4S3 (589.1117232)
6H05 TFA is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C). IC50 value: Target: K-Ras G12C 6H05 gives the greatest degree of modification, which allosterically modifies the oncogenic G12C mutant of highly homologous protein H-Ras without affecting wild-type K-Ras [1]. 6H05 can be used as an intermediate for the synthesis of other oncogenic K-Ras(G12C) inhibitors [2].